447 related articles for article (PubMed ID: 16749216)
1. International Conference on Harmonisation; Guidance on Q8 Pharmaceutical Development; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2006 May; 71(98):29344-5. PubMed ID: 16749216
[TBL] [Abstract][Full Text] [Related]
2. International Conference on Harmonisation; draft guidance on E2F Development Safety Update Report; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2008 Aug; 73(151):45462-3. PubMed ID: 18949880
[TBL] [Abstract][Full Text] [Related]
3. International Conference on Harmonisation; guidance on M4 common technical document; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Oct; 66(200):52634-7. PubMed ID: 12358037
[TBL] [Abstract][Full Text] [Related]
4. International Conference on Harmonisation; guidance on Q8(R1) Pharmaceutical Development; addition of annex; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2009 Jun; 74(109):27325-6. PubMed ID: 19588572
[TBL] [Abstract][Full Text] [Related]
5. International Conference on Harmonisation; guidance on the M4 Common Technical Document--Quality: Questions and Answers/Location Issues; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2004 Jun; 69(111):32358-9. PubMed ID: 15188781
[TBL] [Abstract][Full Text] [Related]
6. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
[TBL] [Abstract][Full Text] [Related]
7. International Conference on Harmonisation; guidance on electronic common technical document specification; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Apr; 68(63):16060-1. PubMed ID: 12674113
[TBL] [Abstract][Full Text] [Related]
8. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
[TBL] [Abstract][Full Text] [Related]
9. International Conference on Harmonisation; Guidance on E2F Development Safety Update Report; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2011 Aug; 76(163):52667-8. PubMed ID: 21894658
[TBL] [Abstract][Full Text] [Related]
10. International Conference on Harmonisation; Guidance on S8 Immunotoxicity Studies for Human Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2006 Apr; 71(71):19193-4. PubMed ID: 16612859
[TBL] [Abstract][Full Text] [Related]
11. International Conference on Harmonisation: guidance on Q1D bracketing and matrixing designs for stability testing of new drug substances and products; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Jan; 68(11):2339-40. PubMed ID: 12532979
[TBL] [Abstract][Full Text] [Related]
12. International Conference on Harmonisation; revised guidance on Q3A impurities in new drug substances; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Feb; 68(28):6924-5. PubMed ID: 12583358
[TBL] [Abstract][Full Text] [Related]
13. International Conference on Harmonisation; Guidance on Q11 Development and Manufacture of Drug Substances; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2012 Nov; 77(224):69634-5. PubMed ID: 23227566
[TBL] [Abstract][Full Text] [Related]
14. International Conference on Harmonisation; revised guidance on Q3B(R) Impurities in New Drug Products; Availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Nov; 68(220):64628-9. PubMed ID: 14619944
[TBL] [Abstract][Full Text] [Related]
15. International Conference on Harmonisation; guidance on E2E Pharmacovigilance Planning; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2005 Apr; 70(62):16827-8. PubMed ID: 15803631
[TBL] [Abstract][Full Text] [Related]
16. International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2000 Dec; 65(242):78493-4. PubMed ID: 12362934
[TBL] [Abstract][Full Text] [Related]
17. International Conference on Harmonisation; evaluation of stability data; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2004 Jun; 69(110):32010-1. PubMed ID: 15185712
[TBL] [Abstract][Full Text] [Related]
18. International Conference on Harmonisation; guidance on S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2005 Oct; 70(202):61133-4. PubMed ID: 16237859
[TBL] [Abstract][Full Text] [Related]
19. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 9 on Tablet Friability General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2010 Apr; 75(64):17147-8. PubMed ID: 20383922
[TBL] [Abstract][Full Text] [Related]
20. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 7 on Dissolution Test General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2010 Apr; 75(64):17148-9. PubMed ID: 20383923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
